Records containing: Malignant Neoplasm
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-27Randomized Trial of Recruitment Strategies for Early Phase Therapeutic Cancer Trials
-
CLINICAL_TRIALS study record update · 2026-04-24KEYMAKER-U01 Substudy 01J: A Randomized Phase 2 Umbrella Study With Rolling Arms of Investigational Agents for First-line Treatment of Participants With Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With KRAS G12C Mutations
-
CLINICAL_TRIALS study record update · 2026-04-24A Phase I Trial of Bevacizumab, Temsirolimus Alone and in Combination With Valproic Acid, or Cetuximab in Patients With Advanced Malignancy and Other Indications
-
CLINICAL_TRIALS study record update · 2026-04-24Phase 1/2 Study of TSN1611 in Subjects With Advanced Solid Tumors Harboring KRAS G12D Mutation
-
CLINICAL_TRIALS study record update · 2026-04-24Evaluation of Intraoperative Tumor Margin Identification With Fluorescent Dye Imaging
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-23A Phase 1 Cellular Immunotherapy Study of Intraventricularly Administered Autologous HER2-Targeted Chimeric Antigen Receptor (HER2-CAR) T Cells in Patients With Brain and/or Leptomeningeal Metastases From HER2 Positive Cancers
-
CLINICAL_TRIALS study record update · 2026-04-23Inhalation Approaches to Nausea: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-04-17A Phase I/II Study of Pembrolizumab (MK-3475) in Japanese Pediatric Participants With Specific Solid Tumors or Lymphomas, or in Japanese Adult Participants With Advanced Merkel Cell Carcinoma (KEYNOTE-G21)
-
CLINICAL_TRIALS study record update · 2026-04-17Targeted Genomic Analysis of Human Cancers
-
CLINICAL_TRIALS study record update · 2026-04-17Exceptional Responders Pilot Study: Molecular Profiling of Tumors From Cancer Patients Who Are Exceptional Responders
-
CLINICAL_TRIALS study record update · 2026-04-15The Patient-Driven Self-Navigated Web-Based Family Outreach Program for Cancer Prevention in High-Risk Families
-
CLINICAL_TRIALS study record update · 2026-04-13A Multicenter, Open-label, Phase 2 Basket Study of MK-5684 in Participants With Selected Solid Tumors (OMAHA-015)
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 1, Open-Label, Multicenter Study to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy of MK-4716 as Monotherapy and as Part of Combination Therapy in Participants With KRAS-Altered Advanced or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-04-13LIGHTBEAM-U01 Substudy 01C: A Phase 1/2 Substudy to Evaluate the Safety and Efficacy of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase Ib/II, Open-label Study of NBM-BMX as Monotherapy or in Combination With Radiotherapy and Temozolomide in Subjects With Solid Tumors or Newly Diagnosed Glioblastoma
-
CLINICAL_TRIALS study record update · 2026-04-02A Single-arm, Open-label, Single-center Clinical Study to Evaluate CDH3-targeted Positron Emission Tomography (PET) for Lung Malignant Tumors
-
CLINICAL_TRIALS study record update · 2026-04-02Protocol for Immunology Specimen Collection From Cancer Patients, Patients With Hematologic Diagnoses, and Healthy Normal Controls
-
CLINICAL_TRIALS study record update · 2026-03-23Construction and Evaluation of Tumor Immunotherapy and Organ Damage Early Warning System Based on Multi-omics
-
CLINICAL_TRIALS study record update · 2026-03-16MC1193: Collaborative Care to Preserve Performance in Cancer (COPE)
-
CLINICAL_TRIALS study record update · 2026-03-16A Phase 1 Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-4700 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-03-06Randomized Trial of Recruitment Strategies for Early Phase Therapeutic Cancer Trials
-
CLINICAL_TRIALS study record update · 2026-02-27The Project: EveryChild Protocol: A Registry, Eligibility Screening, Biology and Outcome Study
-
CLINICAL_TRIALS study record update · 2026-02-27DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial): An Umbrella-Basket Platform Trial to Evaluate the Efficacy of Targeted Therapies in Rare Adult, Paediatric and Teenage/Young Adult (TYA) Cancers With Actionable Genomic Alterations, Including Common Cancers With Rare Actionable Alterations. Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and TYA Patients With BRAF V600 Mutation-Positive Cancers.
-
CLINICAL_TRIALS study record update · 2026-02-20Measuring Changes in Body Composition and Physical Function in Patients With Childhood Cancers
-
CLINICAL_TRIALS study record update · 2026-02-19A Phase 1/2 Open-label Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors